These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 26884472)

  • 1. Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.
    Sherr JL; Ruedy KJ; Foster NC; Piché CA; Dulude H; Rickels MR; Tamborlane WV; Bethin KE; DiMeglio LA; Fox LA; Wadwa RP; Schatz DA; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
    Diabetes Care; 2016 Apr; 39(4):555-62. PubMed ID: 26884472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.
    Rickels MR; Ruedy KJ; Foster NC; Piché CA; Dulude H; Sherr JL; Tamborlane WV; Bethin KE; DiMeglio LA; Wadwa RP; Ahmann AJ; Haller MJ; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
    Diabetes Care; 2016 Feb; 39(2):264-70. PubMed ID: 26681725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.
    Stenninger E; Aman J
    Diabetologia; 1993 Oct; 36(10):931-5. PubMed ID: 8243872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
    Pontiroli AE; Ceriani V
    Diabetes Obes Metab; 2018 Aug; 20(8):1812-1816. PubMed ID: 29652110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog.
    Hövelmann U; Bysted BV; Mouritzen U; Macchi F; Lamers D; Kronshage B; Møller DV; Heise T
    Diabetes Care; 2018 Mar; 41(3):531-537. PubMed ID: 29273578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus.
    Hövelmann U; Olsen MB; Mouritzen U; Lamers D; Kronshage B; Heise T
    Diabetes Obes Metab; 2019 Mar; 21(3):601-610. PubMed ID: 30350477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Usability of Intranasal Glucagon for the Management of Hypoglycemia in Patients With Diabetes: A Systematic Review.
    Singh-Franco D; Moreau C; Levin AD; Rosa D; Johnson M
    Clin Ther; 2020 Sep; 42(9):e177-e208. PubMed ID: 32873417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycaemia in childhood diabetes. II. Effect of subcutaneous or intramuscular injection of different doses of glucagon.
    Aman J; Wranne L
    Acta Paediatr Scand; 1988 Jul; 77(4):548-53. PubMed ID: 3394508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal Glucagon: A New Way to Treat Hypoglycemic Emergencies.
    Lowe RN; Trujillo JM
    Ann Pharmacother; 2020 Aug; 54(8):780-787. PubMed ID: 32052651
    [No Abstract]   [Full Text] [Related]  

  • 10. Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis.
    Pontiroli AE; Tagliabue E
    Acta Diabetol; 2020 Jun; 57(6):743-749. PubMed ID: 32025860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-dependent diabetes.
    Freychet L; Rizkalla SW; Desplanque N; Basdevant A; Zirinis P; Tchobroutsky G; Slama G
    Lancet; 1988 Jun; 1(8599):1364-6. PubMed ID: 2898045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal glucagon as remedy for hypoglycemia. Studies in healthy subjects and type I diabetic patients.
    Pontiroli AE; Calderara A; Pajetta E; Alberetto M; Pozza G
    Diabetes Care; 1989 Oct; 12(9):604-8. PubMed ID: 2676430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial.
    Battelino T; Tehranchi R; Bailey T; Dovc K; Melgaard A; Yager Stone J; Woerner S; von dem Berge T; DiMeglio L; Danne T
    Pediatr Diabetes; 2021 Aug; 22(5):734-741. PubMed ID: 33934456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions.
    La Sala L; Pontiroli AE
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal glucagon in the treatment of hypoglycaemia in type 1 (insulin-dependent) diabetic patients.
    Rosenfalck AM; Bendtson I; Jørgensen S; Binder C
    Diabetes Res Clin Pract; 1992 Jul; 17(1):43-50. PubMed ID: 1511660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia.
    Pontiroli AE; Tagliabue E
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal glucagon: a promising approach for treatment of severe hypoglycemia.
    Pontiroli AE
    J Diabetes Sci Technol; 2015 Jan; 9(1):38-43. PubMed ID: 25385946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting.
    Deeb LC; Dulude H; Guzman CB; Zhang S; Reiner BJ; Piché CA; Pradhan S; Zhang XM
    Pediatr Diabetes; 2018 Aug; 19(5):1007-1013. PubMed ID: 29512902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal glucagon in the treatment of hypoglycaemic attacks in children: experience at a summer camp.
    Slama G; Reach G; Cahane M; Quetin C; Villanove-Robin F
    Diabetologia; 1992 Apr; 35(4):398. PubMed ID: 1516770
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucose recovery after intranasal glucagon during hypoglycaemia in man.
    Hvidberg A; Djurup R; Hilsted J
    Eur J Clin Pharmacol; 1994; 46(1):15-7. PubMed ID: 7911762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.